SYCP1: A Protein Involved in Cell Signaling and Angiogenesis as A Potential Drug Target

Target Name: SYCP1

NCBI ID: G6847

SYCP1

SYCP1: A Protein Involved in Cell Signaling and Angiogenesis as A Potential Drug Target

SYCP1 (Sec-Fc-Tyr-Phe-Glu-Pro) is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the fertilization protein family, which includes proteins that are involved in cell signaling and signaling pathways.

One of the unique features of SYCP1 is its structure. It is a transmembrane protein that is composed of four distinct domains: a catalytic center, a transmembrane region, a intracellular region, and an extracellular region. The catalytic center is the site where the protein carries out its function, which is to catalyze the hydrolysis of the amino acid Asp.

SYCP1 functions as a negative regulator of the protein kinase B-cell src/FAK signaling pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival. In addition, SYCP1 is also involved in the regulation of cell adhesion and migration..

SYCP1 is a protein that has been identified as a potential drug target in the field of cancer. Studies have shown that high levels of SYCP1 are associated with poor prognosis in various types of cancer, including breast, ovarian, and colorectal cancers. Additionally, SYCP1 has also been shown to be involved in the regulation of the angiogenesis, which is the process by which new blood vessels are formed. This suggests that it may be a useful target for drugs that are designed to inhibit angiogenesis.

Another potential mechanism by which SYCP1 may be targeted by drugs is its role in cell signaling. As mentioned earlier, SYCP1 is involved in the regulation of the B-cell src/FAK signaling pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival. By inhibiting the activity of this pathway, drugs may be able to treat a variety of diseases, including cancer.

In addition, SYCP1 is also involved in the regulation of cell adhesion and migration. This suggests that it may be a useful target for drugs that are designed to promote cell detachment and migration. This could be useful for the treatment of diseases such as cancer, where cells have become too closely adhered to surrounding tissue and are difficult to remove.

Another potential mechanism by which SYCP1 may be targeted by drugs is its role in the regulation of angiogenesis. This suggests that it may be a useful target for drugs that are designed to inhibit angiogenesis. This could be useful for the treatment of diseases such as cancer , where new blood vessels are being formed.

In conclusion, SYCP1 is a protein that is involved in various signaling pathways in the body. It is a potential drug target due to its role in the regulation of cell signaling, cell adhesion, and migration. Additionally, its role in the regulation of angiogenesis also makes it a potential target for drugs that are designed to inhibit angiogenesis. Further research is needed to fully understand the potential mechanisms of SYCP1 and its potential as a drug target.

Protein Name: Synaptonemal Complex Protein 1

Functions: Major component of the transverse filaments of synaptonemal complexes, formed between homologous chromosomes during meiotic prophase. Required for normal assembly of the central element of the synaptonemal complexes. Required for normal centromere pairing during meiosis. Required for normal meiotic chromosome synapsis during oocyte and spermatocyte development and for normal male and female fertility

The "SYCP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYCP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets